First Page | Document Content | |
---|---|---|
Date: 2014-07-07 10:35:12Medicine Glatiramer acetate Chronic cerebrospinal venous insufficiency Natalizumab McDonald criteria Experimental autoimmune encephalomyelitis Interferon beta-1b Myelin Interferon beta-1a Multiple sclerosis Immunology Immune system | Microsoft Word - Timeline of Research 7_2014Add to Reading ListSource URL: www.nationalmssociety.orgDownload Document from Source WebsiteFile Size: 57,81 KBShare Document on Facebook |
Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2DocID: 1rmwo - View Document | |
PDF DocumentDocID: 1rhTx - View Document | |
PDF DocumentDocID: 1ptj0 - View Document | |
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr COPAXONE® Glatiramer acetateDocID: 1kIzm - View Document | |
Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulatorsDocID: 1fWCE - View Document |